Merck to start new trial to test Alzheimer's drug

(Reuters) - Merck & Co Inc said on Monday it started a new clinical trial to evaluate the safety and effectiveness of its experimental oral drug MK-8931 in patients with mild-to-moderate Alzheimer's disease.

via Reuters: Health News Read More Here..